Chemical engineers have devised a simpler process for incorporating hydrophobic drugs into tablets or other drug formulations, using nanoemulsions. With this method, it may be possible to make many ...
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Aspire Biopharma (ASBP) announced the filing of a new provisional patent application with the United States Patent and ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
Pharmaceutical Technology on MSN
High-dose biologic delivery to become industry standard
As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose ...
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
The global oral solid dosage pharmaceutical formulation market is on a trajectory of significant expansion, projected to grow from USD 6,29,582.6 million in 2024 to USD 8,95,636.0 million by 2034.
CAMBRIDGE, MA -- About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results